The diagnostic value of ultrasound-guided percutaneous transthoracic core-needle biopsy versus computed tomography-guided biopsy in peripheral intrathoracic lesions

El-Shimy, Wafaa S.; El-Emery, Fawzy; El-Zaher, Ayman H. Abd; Elbadry, Amr Arafa; Elsharawy, Dalia Ezzat

doi:10.4103/1687-8426.176660

Cited by 6 publications

(9 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The current study found trends toward increasing incidence of malignancy among smokers' group (95.8%) more than the non-smokers' group (81.3%); (p=0.167), these data are consistent with El-Sharawy et al, [6] who studied retrospectively the differences between pathological results of 50 USguided biopsies and 50 CT-guided biopsies undertaken in pulmonology department in Tanta university hospitals over a 4-years' period, and found association between smoking and higher incidence of malignancy across the Egyptian population. Interestingly adenocarcinoma was also the most commonly encountered lung malignancy followed by squamous cell carcinoma, then large cell carcinoma in their study, while benign lesions were the least pathologically proven diagnoses.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Can Ultrasound Replace CT in Peripheral Lung Biopsy Guidance: A Comparative Study

Khalid¹,

Zayed

2021

The Medical Journal of Cairo University

View full text Add to dashboard Cite

Background: Selecting the most effective guidance method for peripheral lung biopsy is a priority for interventional radiologists. The clinical trials comparing efficacy and safety of ultrasound (US) and computerized tomography (CT) as biopsy-guiding modalities for peripheral lung biopsy techniques are limited in the literature, and most of them are retrospective. Aim of Study:To compare the efficacy and safety of biopsy guided by US versus CT for lung lesions with pleural contact.Patients and Methods: This is a prospective comparative study; included 40 patients underwent image-guided biopsy at Nasser Institute Hospital, Cairo, Egypt. From June 2018 to May 2020. Lesion size, location, length of pleural contact, number of needle passes, and number of tissues cores, procedure times, complications, and histopathology reports were documented for each biopsy. Statistical analysis using Fisher's exact test and t-test, (Alfa-point=0.05).Results: US-guided group had significantly fewer complications; 15% (3/20) versus 40% (8/20) for CT-guided group; (p=0.036). Fewer number of needles passes were required for US-guided biopsies (mean, 2.7 passes ±0.8 (SD) than for CTguided biopsies (mean, 3.4 passes ± 1.2 (SD); p=0.04). Procedural times were significantly shorter in the US-guidance group, with a mean procedure time of 6.3 minutes ±2.2 (SD) compared to 21.8 minutes ±5.7 (SD) for CT-guided biopsies; (p=0.0001). Conclusion:US guidance should be thought of as a primary tool for guidance of peripheral lung lesions' biopsy, because it is superior to CT in safety and time-saving with comparable accuracy.

show abstract

Section: Discussionsupporting

confidence: 91%

“…The favorable safety profile with US compared to CT is reported by many authors in the context of superiority of US-guidance [1,[4][5][6] .…”

Section: Discussionmentioning

confidence: 99%

Can Ultrasound Replace CT in Peripheral Lung Biopsy Guidance: A Comparative Study

Khalid¹,

Zayed

2021

The Medical Journal of Cairo University

View full text Add to dashboard Cite

show abstract

“…The overall thoracic US-guided biopsy diagnostic yield in our study was 78.0% (32/41), which is lower than that reported in previous studies. 2,3,18,20,[38][39][40][41][42] All patients with negative thoracic US-guided biopsy yield had mass size !5 cm with significant necrosis within the mass compared to those with positive yield (66.7% vs. 40.6%, p ¼ 0.005). Therefore, the lower diagnostic yield encountered in our study could be attributed to larger mass size and tissue necrosis.…”

Section: Discussionmentioning

confidence: 99%

“…Haemoptysis and pneumothorax are the most frequent complications of transthoracic needle biopsy and are mostly mild and self-limiting. 18,38,39,[42][43][44]…”

Section: Discussionmentioning

confidence: 99%

The usefulness of thoracic ultrasonography in diagnosis and staging of bronchogenic carcinoma

et al. 2017

View full text Add to dashboard Cite

show abstract

“…2 However, US guidance has been shown to have up to 41% shorter procedure times than CCT while maintaining a similar safety profile and equivalent diagnostic adequacy. [3][4][5][6][7][8] Similarly, CBCT-guided biopsies of central lung lesions have been shown to be faster than those done with CCT, with comparable safety and adequacy. However, CBCT-guided lung biopsies have not been investigated for subpleural and pleural lesions or specifically compared to US-guided biopsies.…”

Section: Introductionmentioning

confidence: 99%

Ultrasound- Versus CT-Guided Subpleural Lung and Pleural Biopsy: An Analysis of Wait Times, Procedure Time, Safety, and Diagnostic Adequacy

2020

View full text Add to dashboard Cite

Purpose: To compare the wait times, safety, and diagnostic adequacy of computed tomography (CT)–guided percutaneous lung biopsies with ultrasound (US) guidance for subpleural lung and pleural lesions. Methods: Consecutive CT- and US-guided biopsies performed at our institution between January 2018 and January 2019 were retrospectively reviewed. Biopsy wait times, lesion size, degree of pleural contact, procedure duration, number of needle passes, complications, and pathologic diagnosis were recorded and compared. Results: A total of 158 biopsies of subpleural or pleural-based lesions were reviewed. Forty-three cases utilized US guidance, while 115 cases used CT, 41 with conventional CT (CCT), and 74 with cone-beam CT guidance (CBCT). Overall, the mean lesion maximum axial diameter and length of pleural contact for US-guided biopsies was greater than for CT (4.8 ± 2.6 cm vs 3.2 ± 1.9 cm and 4.0 ± 2.5 cm vs 2.6 ± 1.7 cm, respectively, P < .001). Wait times for US-guided biopsies were significantly shorter than CCT by 10.9 days on average while being equivalent to CBCT. Procedure time was shorter for lesions localized with US than CT (29.5 ± 16.4 minutes vs 37.6 ± 19.5 minutes, P = .007) despite CT using less needle passes per lesion (3.5 ± 1.1 vs 3.1 ± 0.8, P = .034). Sample adequacy was equivalent for both modalities (88% for US and 92% for CT). The frequency of pneumothoraces was similar between US (12%) and CT (15%). Conclusion: Ultrasound and CT guidance have similar safety and diagnostic adequacy for subpleural lung and pleural biopsies. Ultrasound guidance has shorter wait and procedure times.

show abstract

The diagnostic value of ultrasound-guided percutaneous transthoracic core-needle biopsy versus computed tomography-guided biopsy in peripheral intrathoracic lesions

Cited by 6 publications

References 31 publications

Can Ultrasound Replace CT in Peripheral Lung Biopsy Guidance: A Comparative Study

Can Ultrasound Replace CT in Peripheral Lung Biopsy Guidance: A Comparative Study

The usefulness of thoracic ultrasonography in diagnosis and staging of bronchogenic carcinoma

Ultrasound- Versus CT-Guided Subpleural Lung and Pleural Biopsy: An Analysis of Wait Times, Procedure Time, Safety, and Diagnostic Adequacy

Contact Info

Product

Resources

About